<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardio</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиология</journal-title><trans-title-group xml:lang="en"><trans-title>Kardiologiia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0022-9040</issn><issn pub-type="epub">2412-5660</issn><publisher><publisher-name>Kardiomag</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18087/cardio.2020.8.n996</article-id><article-id custom-type="elpub" pub-id-type="custom">cardio-996</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group></article-categories><title-group><article-title>Полиморфный локус rs1061624 ТNFR2 ассоциирован с развитием артериальной гипертонии у мужчин</article-title><trans-title-group xml:lang="en"><trans-title>Polymorphic locus rs1061624 of the ТNFR2 gene is associated with the development of arterial hypertension in males</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0769-4095</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Москаленко</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Moskalenko</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">mariam31011989@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5652-0166</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономаренко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomarenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><email xlink:type="simple">ponomarenko_i@bsu.edu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1237-9911</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миланова</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Milanova</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., врач-невролог ОГБУЗ Белгородской областной клинической больницы Святителя Иоасафа</p></bio><bio xml:lang="en"><p>candidate of medical sciences, neurologist, Belgorod Regional Clinical Hospital of St. Joasaph</p></bio><email xlink:type="simple">snezh2302@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5146-3660</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Верзилина</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Verzilina</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., доцент каф. медико-биологических дисциплин медицинского института НИУ «БелГУ»</p></bio><bio xml:lang="en"><p>PhD, assistant professor of the Department of Biomedical Disciplines of Medical Institute of Belgorod State University</p></bio><email xlink:type="simple">verzilina@bsu.edu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6395-1626</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефремова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Efremova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., заведующая кафедрой внутренних болезней №2 медицинского института НИУ «БелГУ»</p></bio><bio xml:lang="en"><p>Doctor of Medical Sciences, Head of the Department of Internal Diseases №2 of the Medical Institute, Belgorod State University</p></bio><email xlink:type="simple">efremova@bsu.edu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6280-247X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полоников</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Polonikov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor, Professor of the Department of Biology, Medical Genetics and Ecology, director of the Research Institute of Genetic and Molecular Epidemiology of KSMU</p></bio><email xlink:type="simple">polonikov@rambler.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Белгородский государственный национальный исследовательский университет», Белгород, Россия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Autonomous Educational Institution of Higher Education «Belgorod National Research University», Belgorod, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Белгородская областная клиническая больница Святителя Иоасафа», Белгород, Россия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Belgorod Regional Clinical Hospital of St. Joasaph, Belgorod, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБОУ ВО «Курский государственный медицинский университет» Минздрава РФ, Курск, Россия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kursk State Medical University, Kursk, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>17</day><month>09</month><year>2020</year></pub-date><volume>60</volume><issue>8</issue><fpage>78</fpage><lpage>83</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kardiomag, 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Kardiomag</copyright-holder><copyright-holder xml:lang="en">Kardiomag</copyright-holder><license xlink:href="https://cardio.elpub.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://cardio.elpub.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://cardio.elpub.ru/jour/article/view/996">https://cardio.elpub.ru/jour/article/view/996</self-uri><abstract><p>Цель Изучение вовлеченности полиморфных локусов цитокинов в развитие артериальной гипертонии (АГ) у мужчин Центрально-Черноземного региона России.Материалы и методы Обследован 821 мужчина: 564 пациента с АГ и 257 индивидуумов контрольной группы. Анализ 8 однонуклеотидных полиморфизмов (ОНП) цитокинов проводился с помощью полимеразной цепной реакции в режиме реального времени при помощи TagMan зондов. Статистическая обработка результатов осуществлялась с помощью программного обеспечения STATISTICA (v.10.0) и PLINK (v.1.06). Регуляторный потенциал ОНП анализировался с использованием сервиса HaploReg, v.4.1 (http://archive.broadinstitute.org).Результаты Выявлено, что полиморфный локус rs1061624 ТNFR2 ассоциирован с развитием АГ у мужчин в рецессивной (отношение шансов (ОШ) =0,33, 95 % доверительный интервал (ДИ): 0,18–0,61, рperm=0,0004) и аддитивной (ОШ=0,50, 95 % ДИ: 0,34–0,74, рperm=0,0006) генетических моделях и оказывает протективный эффект при развитии заболевания. Показано, что ОНП rs1061624 гена ТNFR2 имеет регуляторное значение – располагается в участках ДНК, гиперчувствительных к действию ДНКазы-1, и сайтах связывания с транскрипционными факторами и гистонами, маркирующими энхансеры и промоторы в различных органах и тканях.Заключение Генетический полиморфизм rs1061624 ТNFR2 вовлечен в формирование АГ у мужчин Центрально-Черноземного региона России.</p></abstract><trans-abstract xml:lang="en"><p>Aim To study the involvement of cytokine polymorphous loci in development of arterial hypertension (AH) in men from the Central Black Earth region of Russia.Materials and methods 821 men were evaluated, including 564 patients with AH and 257 individuals of the control group. Analysis of 8 cytokine mononucleotide polymorphisms (MNP) was performed using the real-time polymerase chain reaction with TagMan probes. Statistical analysis was performed with the STATISTICA (v.10.0) and PLINK (v.1.06) software. The regulatory potential of MNP was analyzed with the HaploReg (v.4.1) service (http://archive.broadinstitute.org).Results The rs1061624 ТNFR2 polymorphous locus was associated with development of AH in men in recessive (odd ratio (OR), 0.33; 95 % confidence interval (CI): 0.18–0.61, рperm=0.0004) and additive (OR, 0.50, 95 % CI: 0.34–0.74, рperm=0.0006) genetic models and exerted a protective effect in development of AH. The rs1061624 MNP of the ТNFR2 gene has a regulatory significance; it is located in the DNA sites hypersensitive to the action of DNAase 1 and in binding sites for transcriptional factors and histones that mark enhancers and promoters in different organs and tissues.Conclusion The rs1061624 ТNFR2 gene polymorphism is involved in the development of AH in men of the Central Black Earth region of Russia.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Артериальная гипертония</kwd><kwd>гены цитокинов</kwd><kwd>однонуклеотидный полиморфизм</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Arterial hypertension</kwd><kwd>cytokine genes</kwd><kwd>mononucleotide polymorphism</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке гранта Президента Российской Федерации для ведущих научных школ Российской Федерации (проект НШ-2609.2020.7). Конфликт интересов не заявлен</funding-statement><funding-statement xml:lang="en">This study was supported by a grant from the President of the Russian Federation for leading scientific schools of the Russian Federation (project NSh-2609.2020.7). No conflict of interest is reported.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: ESC/ESH Task Force for the Management of Arterial Hypertension. Journal of Hypertension. 2018;36(12):2284–309. DOI: 10.1097/HJH.0000000000001961</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: ESC/ESH Task Force for the Management of Arterial Hypertension. Journal of Hypertension. 2018;36(12):2284–309. DOI: 10.1097/HJH.0000000000001961</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pietri P, Vlachopoulos C, Tousoulis D. Inflammation and Arterial Hypertension: From Pathophysiological Links to Risk Prediction. Current Medicinal Chemistry. 2015;22(23):2754–61. DOI: 10.2174/0929867322666150420104727</mixed-citation><mixed-citation xml:lang="en">Pietri P, Vlachopoulos C, Tousoulis D. Inflammation and Arterial Hypertension: From Pathophysiological Links to Risk Prediction. Current Medicinal Chemistry. 2015;22(23):2754–61. DOI: 10.2174/0929867322666150420104727</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sirotina S, Ponomarenko I, Kharchenko A, Bykanova M, Bocharova A, Vagaytseva K et al. A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease. Disease Markers. 2018;2018:5812802. DOI: 10.1155/2018/5812802</mixed-citation><mixed-citation xml:lang="en">Sirotina S, Ponomarenko I, Kharchenko A, Bykanova M, Bocharova A, Vagaytseva K et al. A Novel Polymorphism in the Promoter of the CYP4A11 Gene Is Associated with Susceptibility to Coronary Artery Disease. Disease Markers. 2018;2018:5812802. DOI: 10.1155/2018/5812802</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Teixeira BC, Lopes AL, Macedo RCO, Correa CS, Ramis TR, Ribeiro JL et al. Inflammatory markers, endothelial function and cardiovascular risk. Jornal Vascular Brasileiro. 2014;13(2):108–15. DOI: 10.1590/jvb.2014.054</mixed-citation><mixed-citation xml:lang="en">Teixeira BC, Lopes AL, Macedo RCO, Correa CS, Ramis TR, Ribeiro JL et al. Inflammatory markers, endothelial function and cardiovascular risk. Jornal Vascular Brasileiro. 2014;13(2):108–15. DOI: 10.1590/jvb.2014.054</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao F, Zhang R, Zhao H, Liu T, Ren M, Song Y et al. Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(5):588–93. DOI: 10.3760/cma.j.issn.2095-4352.2019.05.013</mixed-citation><mixed-citation xml:lang="en">Zhao F, Zhang R, Zhao H, Liu T, Ren M, Song Y et al. Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31(5):588–93. DOI: 10.3760/cma.j.issn.2095-4352.2019.05.013</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Левченко А.С., Мезенцева О.Ю., Бушуева О.Ю., Воробьева А.А., Фрейдин М.Б., Полонников А.В. и др. Изучение полиморфизмов генов цитокинов IL5, IL1 и TNFα в формировании предрасположенности к хроническому полипозному риносинуситу. Научные результаты биомедицинских исследований. 2018;4(4):10-9. DOI: 10.18413/2313-8955-2018- 4-4-0-2</mixed-citation><mixed-citation xml:lang="en">Levchenko A.S., Mezentseva O.Yu., Bushueva O.Yu., Vorobyova A.A., Freidin M.B., Polonikov A.V. Study of IL5, IL1 and TNFα genes polymorphisms in the predisposition to chronic polypoid rhinosinusitis. Research Results in Biomedicine. 2018;4(4):10–9. DOI: 10.18413/2313-8955-2018- 4-4-0-2</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liaquat A, Shauket U, Ahmad W, Javed Q. The tumor necrosis factor-α -238G/A and IL-6 -572G/C gene polymorphisms and the risk of idiopathic dilated cardiomyopathy: a meta-analysis of 25 studies including 9493 cases and 13,971 controls. Clinical Chemistry and Laboratory Medicine (CCLM). 2015;53(2):307–18. DOI: 10.1515/cclm-2014-0502</mixed-citation><mixed-citation xml:lang="en">Liaquat A, Shauket U, Ahmad W, Javed Q. The tumor necrosis factor-α -238G/A and IL-6 -572G/C gene polymorphisms and the risk of idiopathic dilated cardiomyopathy: a meta-analysis of 25 studies including 9493 cases and 13,971 controls. Clinical Chemistry and Laboratory Medicine (CCLM). 2015;53(2):307–18. DOI: 10.1515/cclm-2014-0502</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Пивоваров А.В. Взаимосвязь инсулиноподобного фактора роста-1 и показателей углеводного обмена у больных с артериальной гипертензией и сахарным диабетом 2 типа. Научный результат. Медицина и фармация. 2017;3(1):8-14. DOI: 10.18413/2313-8955-2017-3-1-8-14</mixed-citation><mixed-citation xml:lang="en">Pyvovarov A.V. Relationship between insulin-like growth factor-1 and indicators of the carbohydrate metabolism in patients with comorbidity of arterial hypertension and type 2 diabetes mellitus. Research Result. Medicine and Pharmacy. 2017;3(1):8–14. DOI: 10.18413/2313-8955-2017-3-1-8-14</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tong Y, Geng Y, Xu J, Wang Z, Zhang Y, Lin L et al. The role of functional polymorphisms of the TNF-α gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case–control studies. Clinica Chimica Acta. 2010;411(17–18):1291–5. DOI: 10.1016/j.cca.2010.05.007</mixed-citation><mixed-citation xml:lang="en">Tong Y, Geng Y, Xu J, Wang Z, Zhang Y, Lin L et al. The role of functional polymorphisms of the TNF-α gene promoter in the risk of ischemic stroke in Chinese Han and Uyghur populations: Two case–control studies. Clinica Chimica Acta. 2010;411(17–18):1291–5. DOI: 10.1016/j.cca.2010.05.007</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. European Journal of Clinical Investigation. 2001;31(10):843–51. DOI: 10.1046/j.1365-2362.2001.00907.x</mixed-citation><mixed-citation xml:lang="en">Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. European Journal of Clinical Investigation. 2001;31(10):843–51. DOI: 10.1046/j.1365-2362.2001.00907.x</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Бритов А.Н., Поздняков Ю.М., Волкова Э.Г., Драпкина О.М., Еганян Р.А., Кисляк О.М. и др. Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная терапия и профилактика. 2011;10(6 S2):2-64</mixed-citation><mixed-citation xml:lang="en">Britov A.N., Pozdnyakov Yu.M., Volkova E.G., Drapkina O.M., Eganyan R.A., Kislyak O.A. et al. National recommendations of cardiovascular prevention. Cardiovascular Therapy and Prevention. 2011;10(6 S2):2–64.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Москаленко М.И., Миланова С.Н., Пономаренко И.В., Полоников А.В., Чурносов М.И. Исследование ассоциаций полиморфизма генов матриксных металлопротеиназ с развитием артериальной гипертензии у мужчин. Кардиология. 2019;59(7S):31-9. DOI: 10.18087/cardio.2598</mixed-citation><mixed-citation xml:lang="en">Moskalenko M.I., Milanova S.N., Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Study of associations of polymorphism of matrix metalloproteinases genes with the development of arterial hypertension in men. Kardiologiia. 2019;59(7S):31–9. DOI: 10.18087/cardio.2598</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Москаленко М.И., Пономаренко И.В., Полоников А.В., Чурносов М.И. Полиморфный локус rs652438 гена MMP12 ассоциирован с развитием артериальной гипертензии у женщин. Артериальная гипертензия. 2019;25(1):60-5. DOI: 10.18705/1607-419X-2019-25-1-60-65</mixed-citation><mixed-citation xml:lang="en">Moskalenko M.I., Ponomarenko I.V., Polonikov A.V., Churnosov M.I. Polymorphic locus rs652438 of the MMP12 gene is associated with the development of hypertension in women. Arterial Hypertension. 2019;25(1):60–5. DOI: 10.18705/1607-419X-2019-25-1-60-65</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Konukoglu D, Uzun H. Endothelial Dysfunction and Hypertension. Advances in Experimental Medicine and Biology. 2017;956:511–40. DOI: 10.1007/5584_2016_90</mixed-citation><mixed-citation xml:lang="en">Konukoglu D, Uzun H. Endothelial Dysfunction and Hypertension. Advances in Experimental Medicine and Biology. 2017;956:511–40. DOI: 10.1007/5584_2016_90</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C et al. A Prospective Study of Soluble Tumor Necrosis Factor- Receptor II (sTNF-RII) and Risk of Coronary Heart Disease Among Women with Type 2 Diabetes. Diabetes Care. 2005;28(6):1376–82. DOI: 10.2337/diacare.28.6.1376</mixed-citation><mixed-citation xml:lang="en">Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C et al. A Prospective Study of Soluble Tumor Necrosis Factor- Receptor II (sTNF-RII) and Risk of Coronary Heart Disease Among Women with Type 2 Diabetes. Diabetes Care. 2005;28(6):1376–82. DOI: 10.2337/diacare.28.6.1376</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Conen D, Cheng S, Steiner LL, Buring JE, Ridker PM, Zee RY. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Womenʼs Genome Health Study. Journal of Hypertension. 2009;27(3):476–83. DOI: 10.1097/HJH.0b013e32832104c8</mixed-citation><mixed-citation xml:lang="en">Conen D, Cheng S, Steiner LL, Buring JE, Ridker PM, Zee RY. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Womenʼs Genome Health Study. Journal of Hypertension. 2009;27(3):476–83. DOI: 10.1097/HJH.0b013e32832104c8</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
